93 related articles for article (PubMed ID: 7509921)
1. Functional domains of human endothelin receptor.
Adachi M; Hashido K; Trzeciak A; Watanabe T; Furuichi Y; Miyamoto C
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S121-4. PubMed ID: 7509921
[TBL] [Abstract][Full Text] [Related]
2. Identification of specific intracellular domains of the human ETA receptor required for ligand binding and signal transduction.
Hashido K; Adachi M; Gamou T; Watanabe T; Furuichi Y; Miyamoto C
Cell Mol Biol Res; 1993; 39(1):3-12. PubMed ID: 8287069
[TBL] [Abstract][Full Text] [Related]
3. Identification of a ligand-binding site of the human endothelin-A receptor and specific regions required for ligand selectivity.
Adachi M; Furuichi Y; Miyamoto C
Eur J Biochem; 1994 Feb; 220(1):37-43. PubMed ID: 8119297
[TBL] [Abstract][Full Text] [Related]
4. Ligand binding domain of the human endothelin-B subtype receptor.
Wada K; Hashido K; Terashima H; Adachi M; Fujii Y; Hiraoka O; Furuichi Y; Miyamoto C
Protein Expr Purif; 1995 Jun; 6(3):228-36. PubMed ID: 7663155
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of human endothelin receptors ETA and ETB identification of regions involved in the selectivity for endothelin 3 or cyclo-(D-Trp-D-Asp-Pro-D-Val-Leu).
Becker A; Haendler B; Hechler U; Schleuning WD
Eur J Biochem; 1994 May; 221(3):951-8. PubMed ID: 8181477
[TBL] [Abstract][Full Text] [Related]
6. Distinct subdomains of human endothelin receptors determine their selectivity to endothelinA-selective antagonist and endothelinB-selective agonists.
Sakamoto A; Yanagisawa M; Sawamura T; Enoki T; Ohtani T; Sakurai T; Nakao K; Toyo-oka T; Masaki T
J Biol Chem; 1993 Apr; 268(12):8547-53. PubMed ID: 8473300
[TBL] [Abstract][Full Text] [Related]
7. Identification of specific regions of the human endothelin-B receptor required for high affinity binding with endothelin-3.
Adachi M; Furuichi Y; Miyamoto C
Biochim Biophys Acta; 1994 Sep; 1223(2):202-8. PubMed ID: 8086489
[TBL] [Abstract][Full Text] [Related]
8. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors.
Rose PM; Krystek SR; Patel PS; Liu EC; Lynch JS; Lach DA; Fisher SM; Webb ML
FEBS Lett; 1995 Mar; 361(2-3):243-9. PubMed ID: 7698331
[TBL] [Abstract][Full Text] [Related]
9. Truncation of N-terminal extracellular or C-terminal intracellular domains of human ETA receptor abrogated the binding activity to ET-1.
Hashido K; Gamou T; Adachi M; Tabuchi H; Watanabe T; Furuichi Y; Miyamoto C
Biochem Biophys Res Commun; 1992 Sep; 187(3):1241-8. PubMed ID: 1417800
[TBL] [Abstract][Full Text] [Related]
10. Identification of a region of the human endothelin ETA receptor required for interaction with bosentan.
Adachi M; Furuichi Y; Miyamoto C
Eur J Pharmacol; 1994 Oct; 269(2):225-34. PubMed ID: 7851498
[TBL] [Abstract][Full Text] [Related]
11. Identification of a domain of ETA receptor required for ligand binding.
Adachi M; Yang YY; Trzeciak A; Furuichi Y; Miyamoto C
FEBS Lett; 1992 Oct; 311(2):179-83. PubMed ID: 1397307
[TBL] [Abstract][Full Text] [Related]
12. Replacement of lysine-181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling.
Zhu G; Wu LH; Mauzy C; Egloff AM; Mirzadegan T; Chung FZ
J Cell Biochem; 1992 Oct; 50(2):159-64. PubMed ID: 1429881
[TBL] [Abstract][Full Text] [Related]
13. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.
Postina R; Kojro E; Fahrenholz F
Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828
[TBL] [Abstract][Full Text] [Related]
14. Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity.
Krystek SR; Patel PS; Rose PM; Fisher SM; Kienzle BK; Lach DA; Liu EC; Lynch JS; Novotny J; Webb ML
J Biol Chem; 1994 Apr; 269(17):12383-6. PubMed ID: 8175640
[TBL] [Abstract][Full Text] [Related]
15. Human endothelin receptor ETB. Amino acid sequence requirements for super stable complex formation with its ligand.
Takasuka T; Sakurai T; Goto K; Furuichi Y; Watanabe T
J Biol Chem; 1994 Mar; 269(10):7509-13. PubMed ID: 8125970
[TBL] [Abstract][Full Text] [Related]
16. The signal peptide of the G protein-coupled human endothelin B receptor is necessary for translocation of the N-terminal tail across the endoplasmic reticulum membrane.
Köchl R; Alken M; Rutz C; Krause G; Oksche A; Rosenthal W; Schülein R
J Biol Chem; 2002 May; 277(18):16131-8. PubMed ID: 11854280
[TBL] [Abstract][Full Text] [Related]
17. Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors.
Breu V; Hashido K; Broger C; Miyamoto C; Furuichi Y; Hayes A; Kalina B; Löffler BM; Ramuz H; Clozel M
Eur J Biochem; 1995 Jul; 231(1):266-70. PubMed ID: 7628480
[TBL] [Abstract][Full Text] [Related]
18. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
Vilardaga JP; Lin I; Nissenson RA
Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
[TBL] [Abstract][Full Text] [Related]
19. Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites.
Simonson MS; Rooney A
Mol Pharmacol; 1994 Jul; 46(1):41-50. PubMed ID: 8058055
[TBL] [Abstract][Full Text] [Related]
20. The ligand-receptor interactions of the endothelin systems are mediated by distinct "message" and "address" domains.
Sakamoto A; Yanagisawa M; Sakurai T; Nakao K; Toyo-oka T; Yano M; Masaki T
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S113-6. PubMed ID: 7509919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
